Glucocorticoid-Induced Increase in Lymphocytic FKBP51 Messenger Ribonucleic Acid Expression: A Potential Marker for Glucocorticoid Sensitivity, Potency, and Bioavailability
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
To reduce the side effects of corticosteroid treatment, the administered dose of glucocorticoids (GCs) should be kept to a minimum while preserving therapeutically needed intracellular levels. Currently available assays to determine individual sensitivity to GCs are either imprecise or based on inhibition by GCs of lymphocyte proliferation following stimulation with phytohemagglutinin or other mitogens, which may influence the GC signal transduction pathway. Using the human lymphoblastoid cell line IM-9 as a model system, we studied whether the GC-induced increase of the mRNA encoding the 51-kDa FK506-binding protein (FKBP51) could be used for the development of a novel assay, ultimately to be used in native human peripheral blood mononuclear cells (PBMCs). GC addition to IM-9 cells resulted in a dose-dependent increase of FKBP51 mRNA levels within 2 h, followed by a further increase until 24 h. Northern blot analysis and real-time PCR yielded similar results. Coincubation of GCs with the GC receptor antagonist ORG 34116 or the protein synthesis inhibitor cycloheximide suggested a direct, GC receptor-mediated up-regulation of FKBP51 gene transcription. Expected differences in potency among different GCs could be readily demonstrated in this system. Extending our observations in IM-9 lymphoblasts to normal PBMCs, we found a dose-dependent increase of FKBP51 mRNA on ex vivo incubation of native human PBMCs with GCs, with a sensitivity of about 10(-9) M for dexamethasone. Moreover, dexamethasone ingestion increased FKBP51 mRNA in PBMCs in vivo, extending the use of this assay to the measurement of GC bioavailability. Finally, using this method we were able to demonstrate partial GC-insensitivity in a 6-month-old infant suffering from congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. We conclude that the induction of FKBP51 mRNA by GCs may be a suitable marker to assess individual GC sensitivity, the in vitro measurement of GC potency, and the in vivo determination of GC bioavailability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of FKBP5 is induced by glucocorticoids, thus forming an ultrashort intracellular negative-feedback loop for GR activity in response to stressor exposure (Vermeer et al, 2003)”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Vermeer et al, 2003
In the citing paper
“FKBP5 induction by GR activation has been proposed as a molecular indicator of GR sensitivity (Ja ¨a ¨skela ¨inen et al, 2011;Vermeer et al, 2003).”
From Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients (2012) · cites this paper as Vermeer et al, 2003
In the citing paper
“FKBP5 is a heatshock protein 90 associated cochaperone of the GR and its expression is strongly induced by glucocorticoids via intronic steroid response elements as part of an intracellular short negative feedback loop for GR activity (Vermeer et al, 2003).”
From Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients (2012) · cites this paper as Vermeer et al, 2003
Citations
Cites
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
Hench, P. S., Kendall, E. C., Slocumb, C. H., & Polley, H. F. (1949) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00526-3 · Cited by 1,179
Quantification on the LightCycler
Rasmussen, R. (2001) · Rapid Cycle Real-Time PCR · doi:10.1007/978-3-642-59524-0_3 · Cited by 892 · cited 1×
“This number was used to relate the initial quantity of cDNA of interest in each sample to one another (21).”
MethodTranscriptional cross-talk, the second mode of steroid hormone receptor action
Göttlicher, M., Heck, S., & Herrlich, P. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050242 · Cited by 388
Mechanism of glucocorticoid receptor down-regulation by glucocorticoids.
Rosewicz, S., McDonald, A. R., Maddux, B. A., Goldfine, I. D., Miesfeld, R. L., & Logsdon, C. D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69104-5 · Cited by 322 · cited 1×
“On the other hand, it has been reported that GCs induce downregulation of GC receptor mRNA itself in IM-9 cells (41).”
BackgroundThe human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit.
Güssow, D., Rein, R., Ginjaar, I., Hochstenbach, F., Seemann, G., Kottman, A., & Ploegh, H. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.9.3132 · Cited by 319 · cited 1×
“Primers used were 5 -AAAAGGCCAAGGAGCACAAC-3 and 5 -TTGAGGAGGGGCCGAGTTC-3 for the FKBP51 PCR (TIB-Molbiol, Berlin, Germany) and 5 -CCAGCAGAGAATGGAAAGTC-3 and 5 -GATGCTGCTTACATGTCTCG-3 for the 2-microglobulin ( 2m) PCR (20).”
MethodHuizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.144 · Cited by 265 · cited 1×
“polymorphisms of the GC receptor (10, 11) and the avail-”
BackgroundSyndromes of Glucocorticoid Resistance
Chrousos, G. P., Detera-Wadleigh, S. D., & Karl, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-11-199312010-00009 · Cited by 235 · cited 1×
“Partial insensitivity to glucocorticoids can be caused by several mechanisms and has been described in many other patients (42).”
BackgroundNair, S. C., Rimerman, R. A., Toran, E. J., Chen, S., Prapapanich, V., Butts, R. N., & Smith, D. F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.594 · Cited by 196 · cited 1×
“The immunophilin FKBP51 forms part of the Hsp90 steroid receptor complex (38) and has been shown to reduce the affinity of both the squirrel monkey and human GC receptor for its ligand when overexpressed (39, 40).”
Background
Cited by
Items 201–293 of 293
Koenen, P., Barczyk, K., Wolf, M., Roth, J., & Viemann, D. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200530 · Cited by 11
Dassonvalle, J., Díaz‐Castro, F., Donoso-Barraza, C., Sepúlveda, C., la Fuente, F. P.-D., Pino, P., Espinosa, A., Chiong, M., Llanos, M. N., & Troncoso, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207582 · Cited by 11
“Moreover, FKBP51 has been described as an important marker for GR sensitivity and bioavailability [11,12].”
BackgroundKok, L., Hillegers, M. H. J., Veldhuijzen, D. S., Boks, M. P., Dieleman, J. M., van Dijk, D., Joëls, M., & Vinkers, C. H. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.05.015 · Cited by 11
Chen, Y., Burckart, G. J., Shah, T., Pravica, V., & Hutchinson, I. V. (2009) · Transplant Immunology · doi:10.1016/j.trim.2008.12.003 · Cited by 9
Savarese, A. M., Grigsby, K. B., Jensen, B. E., Borrego, M. B., Finn, D. A., Crabbe, J. C., & Ozburn, A. R. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.821859 · Cited by 9
Kinouchi, S., Iga, J., Ueno, S., Yamauchi, K., Numata, S., Song, H., Sumitani, S., Shibuya‐Tayoshi, S., Haku, M., Yasui, T., et al. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.01.039 · Cited by 9
Wang, X., Gao, Y., Qiao, Y., Yv, L., Li, L., & Xu, J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115124 · Cited by 8
Hayashi, Y., Iida, S., Sato, Y. Z., Nakaya, A., Sawada, A., Kaji, N., Kamiya, H., Baba, Y., & Harashimaa, H. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.763 · Cited by 8
DNA Methylation Patterns of Glucocorticoid Pathway Genes in Preterm Birth Among Black Women
Nowak, A. L., Anderson, C. M., Ford, J. L., Mackos, A. R., Ohm, J. E., Saadat, N., Tan, A., Zhao, Y., Misra, D. P., & Giurgescu, C. (2022) · Biological Research For Nursing · doi:10.1177/10998004221099253 · Cited by 8
Mitochondrial–nuclear communication by FKBP51 shuttling
Zgajnar, N. R., Lagadari, M., Gallo, L. I., Piwien‐Pilipuk, G., & Galigniana, M. D. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30386 · Cited by 10
Kung, V. L., Avasare, R. S., Friedman, M., Koon, S. M., Neff, T. L., Protzek, S., Corless, C. L., Krajbich, V., Setthavongsack, N., Ditmore, R., et al. (2023) · Kidney360 · doi:10.34067/kid.0000000000000123 · Cited by 8
Bock, O., Neusch, M., Büsche, G., Mengel, M., & Kreipe, H. H. (2004) · European Journal Of Haematology · doi:10.1046/j.0902-4441.2003.00204.x · Cited by 8
“As described (1, 15), up-regulation of FKBP51 gene expression is strongly inducible by glucocorticoids.”
BackgroundZhou, J., & Gong, X. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.03.034 · Cited by 8
Nemoto, T., & Kakinuma, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189767 · Cited by 7
“However, the induction level of Fkpb5 mRNA may vary across individuals and has been proposed as a marker for GR sensitivity [35,36].”
BackgroundFunctions of the Hsp90-Binding FKBP Immunophilins
Cox, M. B., & Smith, D. F. (2007) · Springer eBooks · doi:10.1007/978-0-387-49310-7_2 · Cited by 8
Li, Y., Jia, H., Wei, X., Zhen, S., He, S., & Zhang, X. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01825-9 · Cited by 7
SUMO conjugation as regulator of the glucocorticoid receptor-FKBP51 cellular response to stress
Liberman, A. C., Budziñski, M. L., Sokn, C., Gobbini, R. P., Ugo, M. B., & ARZT, E. S. (2019) · Steroids · doi:10.1016/j.steroids.2019.108520 · Cited by 8
Gehrand, A. L., Phillips, J. M., Welhouse, K. D., Siddiqui, H., Schulgit, M. J., Hoffman, J., Hunt, H., & Raff, H. (2021) · Endocrinology · doi:10.1210/endocr/bqab232 · Cited by 8
Al‐Alem, U., Mahmoud, A. M., Batai, K., Shah‐Williams, E., Gann, P. H., Kittles, R. A., & Rauscher, G. H. (2021) · Cancers · doi:10.3390/cancers13102261 · Cited by 8
“FKBP5 expression is highly inducible by glucocorticoids and functions as a negative transcriptional regulator of GCR [36].”
BackgroundMorikawa, K., Arima, Y., Nagakura, T., Xu, Y., Fujiyama, A., Kataoka, M., Hanatani, S., Matsuzawa, Y., Izumiya, Y., Yamamoto, E., et al. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153332 · Cited by 6
Fuller, K. C., Gravlee, C. C., McCarty, C., Mitchell, M. M., & Mulligan, C. J. (2021) · American Journal of Physical Anthropology · doi:10.1002/ajpa.24362 · Cited by 6
Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review
Ismail, N. H., Mussa, A., Al‐Khreisat, M. J., Yusoff, S. M., Husin, A., & Johan, M. F. (2023) · Diagnostics · doi:10.3390/diagnostics13142328 · Cited by 6
Lao, W., Fang, M., & Yang, X. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.993 · Cited by 6
Lee, I., Ganesan, A., Kalesinskas, L., Zheng, H., Ahn, H. C., Christenson, S. A., ERZURUM, S. C., Zein, J., Bleecker, E. R., Meyers, D. A., et al. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0125oc · Cited by 5
Cushing Syndrome from Topical Foam Steroid Use in an Adolescent Male
Simson, G. G., Kohn, B., & Axelrod, F. B. (2006) · Clinical Pediatrics · doi:10.1177/000992280604500118 · Cited by 5
Gong, X., & Zhou, J. (2025) · Journal of Behavioral Addictions · doi:10.1556/2006.2025.00060 · Cited by 5
Han, J., Zhu, Y., Pan, D., Xue, H., Wang, S., Peng, Y., Liu, H., He, Y., & Yao, X. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.015 · Cited by 4
Maganga-Bakita, I., Aiken, A. A., Puracchio, M. J., Kentner, A. C., & Hunter, R. G. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.09.010 · Cited by 4
Endocrinology of the Stress Response during Critical Illness
Marik, P. E. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4252-5.50143-x · Cited by 5
Dexamethasone Sensitizes Acute Monocytic Leukemia Cells to Ara-C by Upregulating FKBP51
Sun, H., Liu, X., Wang, L., Cui, B., Mu, W., Xia, Y., Liu, S., Liu, X., Jiao, Y., & Zhao, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.888695 · Cited by 6
Braithwaite, E., Cole, J., Murgatroyd, C., Wright, N., O’Farrelly, C., Barker, B., & Ramchandani, P. G. (2023) · Frontiers in Child and Adolescent Psychiatry · doi:10.3389/frcha.2023.1175299 · Cited by 4
Modulation of HPA Axis Function for Treatment of Mood Disorders
Brothers, S. P., Wahlestedt, C., & Nemeroff, C. B. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00276 · Cited by 4
Role of FK506 binding protein 51 in central nervous system diseases
Peng, H., Wei, Y., Qiu, Y., Bi, R., Zeng, L., Hu, B., & Li, Y. Q. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1725945 · Cited by 3
Functions of the Hsp90-Binding FKBP Immunophilins
Ortiz, N. R., Guy, N. C., Garcia, Y. A., Sivils, J. C., Galigniana, M. D., & Cox, M. B. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-14740-1_2 · Cited by 3
Strelevitz, H., Dehaqani, A. A., Balasco, L., & Bozzi, Y. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16133 · Cited by 3
“FKBP5 is also related to glucocorticoid signalling (Vermeer et al., 2003) and consequently the stress regulation system.”
BackgroundGråberg, T., Strömmer, L., Hedman‐Lagerlöf, E., Uzunel, M., Ehrenborg, E., & Wikström, A. (2015) · Journal of Inflammation Research · doi:10.2147/jir.s84165 · Cited by 3
“5 However, these assays have only been used in limited studies of altered GC responsiveness in clinical states that involve GC dysregulation 5,6 and the assays have not been evaluated in states of severe inflammation.”
Neurobiological Risk Factors and Predictors of Vulnerability and Resilience to PTSD
Bar‐Shai, M., & Klein, E. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7522-5_2 · Cited by 3
Behairy, O. G. A., Mohammad, O. I., Salim, R. F., & Sobeih, A. A. (2022) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-022-00244-6 · Cited by 3
“Steroids cause expressions of FKBP5 by activating glucocorticoid receptor elements [33].”
BackgroundLugenbühl, J. F., Snijders, C., Pernia, C. D., Estruch, M. S., Kenis, G., & Daskalakis, N. P. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70021 · Cited by 2
Zhang, S., Jeon, Y.-J., Han, J., Park, H.-Y., & Chung, C. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102801 · Cited by 2
Cai, M., Wang, S., Liu, M., Lai, B., Chen, C., Ding, J., & Wang, X. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150157 · Cited by 2
Potapova, S., Isakov, Y., Tyulkova, E. I., & Vetrovoy, O. V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062873 · Cited by 2
B cells in anti-tRNA synthetase syndrome patients show an activated, interferon-responsive signature
Wilfong, E. M., Bass, L. E., Crofford, L. J., Bonami, R. H., & The MYSTIC Investigators (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1770291 · Cited by 2
Hadwen, J., Schock, S., Farooq, F., MacKenzie, A., & Plaza‐Díaz, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126295 · Cited by 2
“The activity of 1 mg/kg DEX oral treatments was confirmed by the upregulation of the DEX-responsive gene Fkbp5 in the cortex of C57BL6 mice shown by qRT-PCR [33,34] (Supplementary File, Figure S2A).”
Jo, Y., Greene, T. T., Chiale, C., Zhang, K., Fang, Z., Dallari, S., Marooki, N., Wang, W., & Zúñiga, E. I. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2410092122 · Cited by 2
Alsaffar, S. F., Yenzeel, J. H., & Ghazi, H. F. (2019) · Iraqi Journal of Science · doi:10.24996/ijs.2019.60.12.9 · Cited by 2
“High levels of FKBP51 correlate with resistance to GC therapies for asthma[3] and chronic obstructive pulmonary disease, while diagnostic assays are being developed using FKBP51 as a marker of GC sensitivity[4] Adrenocorticotropic hormone (ACTH), or corticotropin, is a 39 amino acid peptide hormone produced by cells o…”
BackgroundThe Role of FKBP5 in Influenza Virus Infection
Kei, C. P. (2010) · TSpace (University of Toronto) · Cited by 2
Weston, F. I., Sforzini, L., Cattaneo, A., & Pariante, C. M. (2023) · Masterclass in neuroendocrinology · doi:10.1007/978-3-031-21358-8_6 · Cited by 2
Jalalian, M., Pourasghar, M., Majd, A., Ghalehnoei, H., & Kianmehr, Z. (2024) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs-153409 · Cited by 1
Moore, M., Cetinkaya-Un, B., Sarkar, P., Kayisli, U. A., Semerci, N., Teng, M. N., Lockwood, C. J., & Guzeloglu‐Kayisli, O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062471 · Cited by 1
“FKBP51 levels are robustly upregulated by glucocorticoid and, to a lesser extent, by progestins [30–33].”
Caulfield, J. I., Cover, E. M., Lipscomb, J. A., Horton, W. J., Kamens, H. M., & Cavigelli, S. A. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106766 · Cited by 1
Gut microbiota shapes how male and female mice react to acute stress
Vodička, M. (., Vagnerová, K., Gazárková, T., Ergang, P., Balounová, K., Hermanová, P. P., Hudcovic, T., Nováková, L., & Pácha, J. (. (2026) · Brain and Environment · doi:10.1016/j.braen.2026.100020 · Cited by 1
Gene-environment interaction in psychiatry
Grabe, H. J., & der Auwera, S. V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813176-3.00029-8 · Cited by 1
Wietfeldt, N. (2020) · International Journal of Medical Students · doi:10.5195/ijms.2020.437 · Cited by 3
Tafet, G. E. (2022) · Springer eBooks · doi:10.1007/978-3-031-00864-1_4 · Cited by 1
Neurobiology of post-traumatic stress disorder
Đorović, Đ., & Puškaš, L. (2025) · Medicinski podmladak · doi:10.5937/mp76-49506 · Cited by 1
Mechanisms of Reduced Glucocorticoid Sensitivity in Bronchial Asthma
Matsumura, Y. (2012) · InTech eBooks · doi:10.5772/29541
Methods and Applications of Anti‐Inflammatory Assays
Zhao, M. (2009) · Wiley eBooks · doi:10.1002/9780470522202.ch11
Factors Determining Glucocorticoid Sensitivity in Man
Smit, P. (2006) · EUR Research Repository (Erasmus University Rotterdam)
Downstream effects of master regulators in two brain diseases.
Braun, S. B. (2012) · Lund University Publications (Lund University)
Molecular mechanisms of glucocorticoid resistance in childhood acute lymphoblastic leukemia
Tissing, W. J. E. (2006) · RePub (Erasmus University Rotterdam)
Wochnik, G. M. (2004) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.2498 · Cited by 1
Glucocorticoid Sensitivity in Rheumatoid Arthritis
Quax, R. A. M. (2013) · EUR Research Repository (Erasmus University Rotterdam)
Effects of immunosuppressive drugs on human adipose tissue metabolism
Pereira, M. J. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University)
The Co-chaperones FKBP51 and PP5 Control Nuclear Receptor Phosphorylation and Adipogenesis
Stechschulte, L. A. (2013) · OhioLink ETD Center (Ohio Library and Information Network)
Füchsl, A. M. (2015) · University of Regensburg Publication Server (University of Regensburg)
Hynne, M. S. (2008) · NVA (Nasjonalt vitenarkiv)
Wehmeyer, L. (2015) · Open University of Cape Town (University of Cape Town) · Cited by 1
The Role of Glucocorticoid Receptor in the Racial/Ethnic Disparity of Aggressive Breast Cancer
Al‐Alem, U. (2015) · Figshare
Walker, S. E. (2016) · Infoscience (Ecole Polytechnique Fédérale de Lausanne) · doi:10.5075/epfl-thesis-7105
“When GR does translocate, it leads to an upregula on of FKBP5, thereby leading to further enhancement of GR resistance (Vermeer et al., 2003).”
BackgroundExpression and regulation of the rate-limiting enzymes of the kynurenine pathway in the mouse brain
Brooks, A. K. (2017) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation
Hadwen, J. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-21849
Prinzi, G., Tomino, C., Santoro, A., Marcolongo, F., Cardaci, V., Fini, M., Giacconi, R., Malavolta, M., Provinciali, M., Rícci, A., et al. (2019) · Preprints.org · doi:10.20944/preprints201907.0097.v1
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Haehle, A. (2020) · TUbilio (Technical University of Darmstadt) · doi:10.25534/tuprints-00013235
“The fkbp5 gene itself is inducible by glucocorticoids [73-76], progesterone [75,77-79] and androgenic hormones [80-82] leading to both elevated mRNA and protein levels.”
BackgroundGenetic and environmental influences on major depression in youth
Piechaczek, C. (2020) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.26437
“Ties that Bind” Behavior Genetics of Associations Between Attachment and Personality in Adulthood
Franz, C. E., Lewis, G. J., Ramundo, A., & Lyons, M. J. (2020) · Springer eBooks · doi:10.1007/978-1-0716-0933-0_9
Li, J., Zhao, M., & Peng, S. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse306
Treatment of acute Graft-versus-Host Disease using inorganic-organic hybrid nanoparticles
Kaiser, T. K. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7756
Iversen, M., Mulugeta, T. D., Blikeng, B. G., West, A. C., Jørgensen, E. H., Sandve, S. R., & Hazlerigg, D. G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237623
Chapman, K. E. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.6256956.6332054
Tafet, G. E. (2024) · Springer eBooks · doi:10.1007/978-3-031-58285-1_4
Tahri, S., Fakhfakh, R., Bahloul, E., Charfi, S., Sellami, K., Hachicha, H., Boudawara, T. S., Turki, H., Masmoudi, H., & Abida, O. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-03864-1
Nasehi, F., Khodagholi, F., Kaveh, N., Maleki, A., Zeinaddini-Meymand, A., Mousavi, M. A., Minai‐Tehrani, D., & Foolad, F. (2025) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2024.6604.1
“Its level can mirror the efficiency of the GR signaling pathway (Menke et al., 2012; Vermeer et al., 2003).”
Fuller, K. C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.17632/3f46kg3m55
Luchak, A., Solomon, L. A., Kanagalingam, T., Vijeyakumaran, M., Rowe, B. H., & Cameron, L. (2020) · Figshare · doi:10.6084/m9.figshare.13115301
Early life stress and gene regulation from a psycho-biological perspective
Müller, S. (2023) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · doi:10.13154/294-9591
Das, F. (2024) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-36973
Polymorphismen in den Kortisolgenen und Geburtsgewicht
Hübner, T. (2020) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)
Implication du récepteur des glucocorticoïdes en physiopathologie humaine
Vitellius, G. (2019) · theses.fr (ABES) · doi:10.70675/84630f11zbc82z43a6z8604z69024f4ae7dd
SUMOylation modulates glucocorticoid-induced muscle toxicity in cell and mouse models
Lee, A., Jeong, Y., Kwon, H., Kim, M., Kim, S., Lee, P., & Kho, C. (2026) · Scientific Reports · doi:10.1038/s41598-026-60353-9 · Cited by 1
Metadata
- Authors
- Vermeer, H., Hendriks-Stegeman, B. I., van der Burg, B., van Buul-Offers, S. C., & Jansen, M.
- Affiliations
- University Medical Center Utrecht (NL)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-01
- Volume
- 88
- Issue
- 1
- Pages
- 277-284
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2087836842
- Cited by
- 285
- References
- 40
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 5 · 2023: 9 · 2022: 12 · 2021: 11 · 2020: 18 · 2019: 19 · 2018: 12 · 2017: 15 · 2016: 18 · 2015: 18 · 2014: 15 · 2013: 11 · 2012: 17
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- glucocorticoids, FKBP51, FKBP, glucocorticoid receptor, gene transcription, lymphocytes, peripheral blood mononuclear cells, glucocorticoid sensitivity, glucocorticoid potency, dexamethasone, congenital adrenal hyperplasia, 21-hydroxylase deficiency, cycloheximide
- MeSH terms
- Tacrolimus Binding Protein 5, Biological Availability, Computer Systems, Dexamethasone, Drug Resistance, Female, Glucocorticoids, Humans, Infant, Lymphocytes, Receptors, Glucocorticoid, RNA, Messenger, Time Factors, Tumor Cells, Cultured, Blotting, Northern, Biomarkers, Polymerase Chain Reaction, Tacrolimus Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.